NCT02935699View on ClinicalTrials.gov

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

PHASE3CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Acute Urticaria
Interventions
DRUG

Test Drug (JDP-205)

Cetirizine, 10mg/mL; a single 1.0 mL injection via intravenous (IV) push over a period of \~2 minutes

DRUG

Active Control (Diphenhydramine)

Diphenhydramine Injection, 50 mg/mL;a single 1.0 mL injection via intravenous (IV) push over a period of \~2 minutes

Trial Locations (4)

19141

Einstein Medical Center, Philadelphia

45219

Univ of Cincinnati Medical Center, Cincinnati

75209

City Doc Urgent Care center, Dallas

K1Y 4E9

Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

JDP Therapeutics, Inc.

INDUSTRY

NCT02935699 - Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria | Biotech Hunter | Biotech Hunter